Cellosaurus logo
expasy logo

Cellosaurus LB39-MEL (CVCL_F240)

[Text version]
Cell line name LB39-MEL
Synonyms LB39
Accession CVCL_F240
Resource Identification Initiative To cite this cell line use: LB39-MEL (RRID:CVCL_F240)
Comments From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
Characteristics: Established via a mouse xenograft.
Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
HLA typing Source: PubMed=12747757
Class I
HLA-AA*02,24
HLA-BB*07,51
HLA-CC*w01,w07
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 41Y
Category Cancer cell line
Publications

PubMed=10661410; DOI=10.1016/S1074-7613(00)80163-6
Morel S., Levy F., Burlet-Schiltz O., Brasseur F., Probst-Kepper M., Peitrequin A.-L., Monsarrat B., Van Velthoven R., Cerottini J.-C., Boon T., Gairin J.-E., van den Eynde B.J.
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.
Immunity 12:107-117(2000)

PubMed=12747757
Jager E., Karbach J., Gnjatic S., Jager D., Maeurer M.J., Atmaca A., Arand M., Skipper J.C.A., Stockert E., Chen Y.-T., Old L.J., Knuth A.
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Cancer Immun. 2:12-12(2002)

Cross-references
Encyclopedic resources Wikidata; Q54902065
Entry history
Entry creation22-Oct-2012
Last entry update29-Jun-2023
Version number9